Repros Therapeutics, Inc. (RPRX)

[DewDiligence]

…the liver toxicity issues will be resolved!!!

That’s doubtful. A dose low enough to make the toxicity acceptable to the FDA will probably be too low to show meaningful efficacy.

Proellex has less than a 1% chance of making it to market, IMO. If a real drug/biotech company owned this drug, the program would almost certainly have been shelved by now.